NCT07017816
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07017816
Title A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies. (JACOB)
Acronym JACOB
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's National Research Institute
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.